(Q50998617)

26 March 2018

editorial

0 references

review article

1 reference

title

In search of the magic bullet: can liver inflammation and fibrosis be reversed with medications? (English)

1 reference

26 March 2018

author name string

Henning W Zimmermann

series ordinal

1

1 reference

26 March 2018

Frank Tacke

series ordinal

2

1 reference

26 March 2018

publication date

2 July 2015

1 reference

26 March 2018

Expert Review of Gastroenterology & Hepatology

published in

1 reference

26 March 2018

volume

9

1 reference

26 March 2018

issue

9

1 reference

26 March 2018

page(s)

1139-1141

1 reference

26 March 2018

Clinical evidence for the regression of liver fibrosis

cites work

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1063417

Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1063417

Evolving therapies for liver fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1063417

Liver fibrosis and repair: immune regulation of wound healing in a solid organ

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1063417

Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1063417

Macrophage heterogeneity in liver injury and fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1063417

CCL2-dependent infiltrating macrophages promote angiogenesis in progressive liver fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1063417

Differential Ly-6C expression identifies the recruited macrophage phenotype, which orchestrates the regression of murine liver fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1063417

Macrophage therapy for murine liver fibrosis recruits host effector cells improving fibrosis, regeneration, and function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1063417

Bone marrow-derived cells express matrix metalloproteinases and contribute to regression of liver fibrosis in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1063417

Spontaneous recovery from micronodular cirrhosis: evidence for incomplete resolution associated with matrix cross-linking

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1063417

Fluorescent cell-traceable dexamethasone-loaded liposomes for the treatment of inflammatory liver diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1063417

Pharmacological inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1063417

Antagonism of the chemokine Ccl5 ameliorates experimental liver fibrosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1063417

Functions of galectin-3 and its role in fibrotic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1063417

Regression of fibrosis and reversal of cirrhosis in rats by galectin inhibitors in thioacetamide-induced liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1063417

Osteopontin neutralisation abrogates the liver progenitor cell response and fibrogenesis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1063417

Chemokine receptor CCR6-dependent accumulation of γδ T cells in injured liver restricts hepatic inflammation and fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1063417

Interleukin-22 induces hepatic stellate cell senescence and restricts liver fibrosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1063417

IL-22 and IL-22 binding protein (IL-22BP) regulate fibrosis and cirrhosis in hepatitis C virus and schistosome infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1063417

Cannabinoid signaling and liver therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1063417

Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1063417

Allosteric inhibition of lysyl oxidase–like-2 impedes the development of a pathologic microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1063417

10.1586/17474124.2015.1063417

21 January 2018

Identifiers

DOI

1 reference

26 March 2018

1 reference

26 March 2018